The Effects of the Carrier and Ligand Spatial Conformation on RNA Nanodrug Cell Delivery

Zhuang Zhang1, Siying Li1, Hongda Wang2

  • 1School of Chemistry and Life Science, Advanced Institute of Materials Science, Changchun University of Technology, Changchun 130012, China.

Analytical Chemistry
|August 3, 2024
PubMed

Insights

This study explores how RGD ligands and carriers affect small interfering RNA (siRNA) nanodrug delivery for cancer therapy. Findings offer insights into optimizing nanodrug delivery systems for enhanced cancer treatment efficacy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Molecular Biology

Background:

  • Small interfering RNA (siRNA) holds significant therapeutic promise for cancer treatment.
  • Effective delivery of siRNA nanodrugs is crucial but faces challenges related to ligands and carriers.
  • Targeting αVβ3 integrins is a key strategy in siRNA delivery systems.

Purpose of the Study:

  • To analyze the binding specificity and dynamics of linear and circular RGD ligands to αVβ3 integrins.
  • To evaluate the impact of ligands and carriers on the cell entry dynamics of RNA nanodrugs.
  • To assess the delivery efficiency of RNA nanodrugs at the single-cell level.

Main Methods:

  • Super-resolution direct stochastic optical reconstruction microscopy (dSTORM) for morphology mapping.
  • Single-molecule force spectroscopy (SMFS) to investigate binding dynamics.
  • Force tracing technique for evaluating cell entry parameters at the single-particle level.
  • Atomic force microscopy (AFM)-based nanoindentation for assessing delivery efficiency.

Main Results:

  • Detailed analysis of RGD ligand binding specificity and dynamics to αVβ3 integrins.
  • Quantification of ligand and carrier effects on RNA nanodrug cell entry parameters.
  • Demonstration of AFM-based nanoindentation for evaluating nanodrug delivery efficiency.

Conclusions:

  • Understanding ligand-integrin interactions is vital for designing effective siRNA nanodrug delivery systems.
  • The study provides a foundation for rational design strategies to improve nanodrug delivery efficiency.
  • These findings contribute to advancing siRNA-based cancer therapeutics.

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
318
Nucleic Acid Structure01:25

Nucleic Acid Structure

The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms  a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
6.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K